Please Wait.....
Report
Lipid Nanoparticles Market By Type (Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, Others) , By Application (Therapeutics, Research) By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 220 Pages I Allied Market Research
The global lipid nanoparticles market was valued at $0.9 billion in 2023, and is projected to reach $3.1 billion by 2033, growing at a CAGR of 13.1% from 2024 to 2033
Lipid nanoparticles (LNPs) are nanoscale particles ranging from 10 to 1000 nanometers in diameter, primarily composed of lipids. They are designed to encapsulate therapeutic agents such as drugs, vaccines, and genetic materials, protecting them from degradation and enhancing their delivery and efficacy. LNPs can mimic the structure of biological membranes, making them biocompatible and capable of efficiently interacting with and penetrating cells. Their lipid composition typically includes phospholipids, cholesterol, and other lipid molecules that aid in stabilizing the nanoparticle structure and controlling the release of the encapsulated cargo.
The growth of the lipid nanoparticles market is driven by rise in the prevalence of chronic diseases, such as cancer, diabetes, cardiovascular diseases, and neurological disorders, and surge in demand for advanced drug delivery systems. These conditions often require long-term treatment with drugs that have severe side effects when administered through traditional methods. LNPs offer a promising alternative by enabling targeted and sustained delivery of therapeutic agents, thereby reducing systemic side effects and improving patient compliance. In oncology, for instance, LNPs are used to deliver chemotherapeutic agents directly to tumor cells, minimizing damage to healthy tissues.
However, high cost associated with the production and development of LNP-based formulations, as the manufacturing process involves sophisticated technology and stringent quality control measures to ensure the stability and efficacy of the nanoparticles, leads to increased production costs which limit the market growth. On the contrary, advances in nanotechnology facilitated the development of lipid nanoparticles with enhanced stability, targeted delivery, and controlled release properties. This opened new avenues for drug delivery, allowing for more effective and efficient therapeutic interventions. For instance, in January 2022, Pfizer Inc. and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA) -based therapeutics announced that they had entered into a development and option agreement under which Pfizer will have the option to license, on a non-exclusive basis, Acuitas' LNP technology for up to 10 targets for vaccine or therapeutic development.
Segmentation Overview
The lipid nanoparticles market analysis is segmented into type, application, end user, and region. Depending on type, the market is categorized into solid lipid nanoparticles, nanostructured lipid carriers, and others. By application, it is bifurcated into therapeutics and research. As per end user, the market is classified into pharmaceutical & biotechnology companies, academic & research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the solid lipid nanoparticles segment held the highest market share in 2023.
Depending on the application, the therapeutics segment accounted for maximum share in the market in 2023.
According to end user, the pharmaceutical & biotechnology companies have been the largest shareholder in the market in 2023.
Region wise, North America dominated the lipid nanoparticles market in 2023.
Competitive Scenario
The major players operating in the lipid nanoparticles market include ABP Biosciences, LLC., Merck KGaA, Cytiva, CD Bioparticles, CordenPharma, Precigenome LLC., Beam Therapeutics, Acuitas Therapeutics, GENEVANT SCIENCES CORPORATION, and Helix Biotech, Inc. Other players in lipid nanoparticles market includes Arbutus Biopharma, and Croda International Plc. These players have adopted several strategies, including mergers & acquisitions, collaborations, product innovation & diversification, and partnerships, to maintain their foothold in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Type
- Solid Lipid Nanoparticles
- Nanostructured Lipid Carriers
- Others
By Application
- Therapeutics
- Research
By End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- ABP Biosciences, LLC.
- Merck KGaA
- Cytiva
- CD Bioparticles
- CordenPharma
- Precigenome LLC.
- Beam Therapeutics
- Acuitas Therapeutics.
- Helix Biotech, Inc.
- Genevant Sciences Corporation
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: MEDICAL DISPOSABLE PRODUCTS MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Wound Management Products
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Drug Delivery Products
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Diagnostic And Laboratory Disposables
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Dialysis Disposables
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Incontinence Products
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
4.7. Respiratory Supplies
4.7.1. Key Market Trends, Growth Factors and Opportunities
4.7.2. Market Size and Forecast, By Region
4.7.3. Market Share Analysis, By Country
4.8. Sterilization Supplies
4.8.1. Key Market Trends, Growth Factors and Opportunities
4.8.2. Market Size and Forecast, By Region
4.8.3. Market Share Analysis, By Country
4.9. Non-woven Disposables
4.9.1. Key Market Trends, Growth Factors and Opportunities
4.9.2. Market Size and Forecast, By Region
4.9.3. Market Share Analysis, By Country
4.10. Disposable Masks
4.10.1. Key Market Trends, Growth Factors and Opportunities
4.10.2. Market Size and Forecast, By Region
4.10.3. Market Share Analysis, By Country
4.11. Disposable Eye Gear
4.11.1. Key Market Trends, Growth Factors and Opportunities
4.11.2. Market Size and Forecast, By Region
4.11.3. Market Share Analysis, By Country
4.12. Disposable Gloves
4.12.1. Key Market Trends, Growth Factors and Opportunities
4.12.2. Market Size and Forecast, By Region
4.12.3. Market Share Analysis, By Country
4.13. Hand Sanitizers
4.13.1. Key Market Trends, Growth Factors and Opportunities
4.13.2. Market Size and Forecast, By Region
4.13.3. Market Share Analysis, By Country
4.14. Others
4.14.1. Key Market Trends, Growth Factors and Opportunities
4.14.2. Market Size and Forecast, By Region
4.14.3. Market Share Analysis, By Country
CHAPTER 5: MEDICAL DISPOSABLE PRODUCTS MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Cardiovascular
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Cerebrovascular
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Ophthalmology
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Gynecology
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Urology
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
5.7. Orthopedics
5.7.1. Key Market Trends, Growth Factors and Opportunities
5.7.2. Market Size and Forecast, By Region
5.7.3. Market Share Analysis, By Country
5.8. Others
5.8.1. Key Market Trends, Growth Factors and Opportunities
5.8.2. Market Size and Forecast, By Region
5.8.3. Market Share Analysis, By Country
CHAPTER 6: MEDICAL DISPOSABLE PRODUCTS MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Ambulatory Surgery Centers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: MEDICAL DISPOSABLE PRODUCTS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Medical Disposable Products Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Medical Disposable Products Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Medical Disposable Products Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Medical Disposable Products Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Medical Disposable Products Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Medical Disposable Products Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Medical Disposable Products Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Medical Disposable Products Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Medical Disposable Products Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Medical Disposable Products Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Medical Disposable Products Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Medical Disposable Products Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By End User
7.4.9. Australia Medical Disposable Products Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Medical Disposable Products Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Medical Disposable Products Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Medical Disposable Products Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Medical Disposable Products Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Medical Disposable Products Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Medical Disposable Products Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Medline Industries, Inc.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Smith+Nephew
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Bayer AG
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. 3M
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Becton Dickinson And Company
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Cardinal Health
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. B. Braun SE
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Boston Scientific Corporation
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Narang Medical Limited
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Terumo Corporation
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 2. LIPID NANOPARTICLES MARKET FOR SOLID LIPID NANOPARTICLES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. LIPID NANOPARTICLES MARKET FOR NANOSTRUCTURED LIPID CARRIERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. LIPID NANOPARTICLES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. GLOBAL LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 6. LIPID NANOPARTICLES MARKET FOR THERAPEUTICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. LIPID NANOPARTICLES MARKET FOR RESEARCH, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. GLOBAL LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 9. LIPID NANOPARTICLES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. LIPID NANOPARTICLES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. LIPID NANOPARTICLES MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. LIPID NANOPARTICLES MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. NORTH AMERICA LIPID NANOPARTICLES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 17. U.S. LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 18. U.S. LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 19. U.S. LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 20. CANADA LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 21. CANADA LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 22. CANADA LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 23. MEXICO LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 24. MEXICO LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 25. MEXICO LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 26. EUROPE LIPID NANOPARTICLES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 27. EUROPE LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 28. EUROPE LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 29. EUROPE LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 30. GERMANY LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 31. GERMANY LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 32. GERMANY LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 33. FRANCE LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 34. FRANCE LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 35. FRANCE LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 36. UK LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 37. UK LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 38. UK LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 39. ITALY LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 40. ITALY LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 41. ITALY LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 42. SPAIN LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 43. SPAIN LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 44. SPAIN LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 45. REST OF EUROPE LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 46. REST OF EUROPE LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 47. REST OF EUROPE LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 48. ASIA-PACIFIC LIPID NANOPARTICLES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 49. ASIA-PACIFIC LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 50. ASIA-PACIFIC LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 51. ASIA-PACIFIC LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 52. JAPAN LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 53. JAPAN LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 54. JAPAN LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 55. CHINA LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 56. CHINA LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 57. CHINA LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 58. INDIA LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 59. INDIA LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 60. INDIA LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 61. AUSTRALIA LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 62. AUSTRALIA LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 63. AUSTRALIA LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 64. SOUTH KOREA LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 65. SOUTH KOREA LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 66. SOUTH KOREA LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 67. REST OF ASIA-PACIFIC LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 68. REST OF ASIA-PACIFIC LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 69. REST OF ASIA-PACIFIC LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 70. LAMEA LIPID NANOPARTICLES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 71. LAMEA LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 72. LAMEA LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 73. LAMEA LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 74. BRAZIL LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 75. BRAZIL LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 76. BRAZIL LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 77. SAUDI ARABIA LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 78. SAUDI ARABIA LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 79. SAUDI ARABIA LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 80. SOUTH AFRICA LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 81. SOUTH AFRICA LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 82. SOUTH AFRICA LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 83. REST OF LAMEA LIPID NANOPARTICLES MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 84. REST OF LAMEA LIPID NANOPARTICLES MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 85. REST OF LAMEA LIPID NANOPARTICLES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 86. ABP BIOSCIENCES, LLC.: KEY EXECUTIVES
TABLE 87. ABP BIOSCIENCES, LLC.: COMPANY SNAPSHOT
TABLE 88. ABP BIOSCIENCES, LLC.: OPERATING SEGMENTS
TABLE 89. ABP BIOSCIENCES, LLC.: PRODUCT PORTFOLIO
TABLE 90. ABP BIOSCIENCES, LLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 91. MERCK KGAA: KEY EXECUTIVES
TABLE 92. MERCK KGAA: COMPANY SNAPSHOT
TABLE 93. MERCK KGAA: OPERATING SEGMENTS
TABLE 94. MERCK KGAA: PRODUCT PORTFOLIO
TABLE 95. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96. CYTIVA: KEY EXECUTIVES
TABLE 97. CYTIVA: COMPANY SNAPSHOT
TABLE 98. CYTIVA: OPERATING SEGMENTS
TABLE 99. CYTIVA: PRODUCT PORTFOLIO
TABLE 100. CYTIVA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 101. CD BIOPARTICLES: KEY EXECUTIVES
TABLE 102. CD BIOPARTICLES: COMPANY SNAPSHOT
TABLE 103. CD BIOPARTICLES: OPERATING SEGMENTS
TABLE 104. CD BIOPARTICLES: PRODUCT PORTFOLIO
TABLE 105. CD BIOPARTICLES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. CORDENPHARMA: KEY EXECUTIVES
TABLE 107. CORDENPHARMA: COMPANY SNAPSHOT
TABLE 108. CORDENPHARMA: OPERATING SEGMENTS
TABLE 109. CORDENPHARMA: PRODUCT PORTFOLIO
TABLE 110. CORDENPHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 111. PRECIGENOME LLC.: KEY EXECUTIVES
TABLE 112. PRECIGENOME LLC.: COMPANY SNAPSHOT
TABLE 113. PRECIGENOME LLC.: OPERATING SEGMENTS
TABLE 114. PRECIGENOME LLC.: PRODUCT PORTFOLIO
TABLE 115. PRECIGENOME LLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 116. BEAM THERAPEUTICS: KEY EXECUTIVES
TABLE 117. BEAM THERAPEUTICS: COMPANY SNAPSHOT
TABLE 118. BEAM THERAPEUTICS: OPERATING SEGMENTS
TABLE 119. BEAM THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 120. BEAM THERAPEUTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 121. ACUITAS THERAPEUTICS.: KEY EXECUTIVES
TABLE 122. ACUITAS THERAPEUTICS.: COMPANY SNAPSHOT
TABLE 123. ACUITAS THERAPEUTICS.: OPERATING SEGMENTS
TABLE 124. ACUITAS THERAPEUTICS.: PRODUCT PORTFOLIO
TABLE 125. ACUITAS THERAPEUTICS.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 126. HELIX BIOTECH, INC.: KEY EXECUTIVES
TABLE 127. HELIX BIOTECH, INC.: COMPANY SNAPSHOT
TABLE 128. HELIX BIOTECH, INC.: OPERATING SEGMENTS
TABLE 129. HELIX BIOTECH, INC.: PRODUCT PORTFOLIO
TABLE 130. HELIX BIOTECH, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 131. GENEVANT SCIENCES CORPORATION: KEY EXECUTIVES
TABLE 132. GENEVANT SCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 133. GENEVANT SCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 134. GENEVANT SCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 135. GENEVANT SCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL LIPID NANOPARTICLES MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF LIPID NANOPARTICLES MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN LIPID NANOPARTICLES MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALLIPID NANOPARTICLES MARKET
FIGURE 10. GLOBAL LIPID NANOPARTICLES MARKET SEGMENTATION, BY TYPE
FIGURE 11. LIPID NANOPARTICLES MARKET FOR SOLID LIPID NANOPARTICLES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. LIPID NANOPARTICLES MARKET FOR NANOSTRUCTURED LIPID CARRIERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. LIPID NANOPARTICLES MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. GLOBAL LIPID NANOPARTICLES MARKET SEGMENTATION, BY APPLICATION
FIGURE 15. LIPID NANOPARTICLES MARKET FOR THERAPEUTICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. LIPID NANOPARTICLES MARKET FOR RESEARCH, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. GLOBAL LIPID NANOPARTICLES MARKET SEGMENTATION, BY END USER
FIGURE 18. LIPID NANOPARTICLES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. LIPID NANOPARTICLES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. LIPID NANOPARTICLES MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 25. COMPETITIVE DASHBOARD
FIGURE 26. COMPETITIVE HEATMAP: LIPID NANOPARTICLES MARKET
FIGURE 27. TOP PLAYER POSITIONING, 2023
FIGURE 28. ABP BIOSCIENCES, LLC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 29. ABP BIOSCIENCES, LLC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 30. ABP BIOSCIENCES, LLC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 31. MERCK KGAA: NET SALES, 2021-2023 ($BILLION)
FIGURE 32. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 33. MERCK KGAA: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 34. CYTIVA: NET SALES, 2021-2023 ($BILLION)
FIGURE 35. CYTIVA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. CYTIVA: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. CD BIOPARTICLES: NET SALES, 2021-2023 ($BILLION)
FIGURE 38. CD BIOPARTICLES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. CD BIOPARTICLES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. CORDENPHARMA: NET SALES, 2021-2023 ($BILLION)
FIGURE 41. CORDENPHARMA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. CORDENPHARMA: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. PRECIGENOME LLC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. PRECIGENOME LLC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. PRECIGENOME LLC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. BEAM THERAPEUTICS: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. BEAM THERAPEUTICS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. BEAM THERAPEUTICS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. ACUITAS THERAPEUTICS.: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. ACUITAS THERAPEUTICS.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. ACUITAS THERAPEUTICS.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52. HELIX BIOTECH, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 53. HELIX BIOTECH, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54. HELIX BIOTECH, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 55. GENEVANT SCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 56. GENEVANT SCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 57. GENEVANT SCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security